Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Intercell> ?p ?o }
- Intercell abstract "Intercell AG was a biotechnology company based in Vienna which focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases. Intercell was formed in 1998 as a spin-off of the Research Institute of Molecular Pathology (IMP) in Vienna.It employs 400 people in Austria, Scotland and the United States.It has been listed on the Vienna Stock Exchange since February 28, 2005. In 2008, Intercell signaled its intent to acquire Maryland-based Iomai, a developer of needle-free vaccination technology.Intercell cooperates with pharmaceutical companies like Novartis, Merck and Sanofi-Aventis on vaccine production.The most important projects of Intercell are: Vaccine against Japanese encephalitis (approved in Europe, America and Australia) Therapeutic vaccine against hepatitis C (in clinical phase II) Antigen identification program and adjuvant technologies. Vaccine Enhancement Patch to improve prevention against pandemic influenza (in collaboration with U.S. Department of Health and Human Services, in clinical phase II)↑ 1.0 1.1 1.2 1.3 1.4 1.5 ↑ ↑ ↑ ↑ ↑ ↑ ↑".
- Intercell assets "2.252E8".
- Intercell equity "1.211E8".
- Intercell extinctionYear "2013".
- Intercell fate "Merged with Vivalis SA".
- Intercell foundingYear "1998".
- Intercell industry Biotechnology.
- Intercell internationally "true".
- Intercell keyPerson Chairman.
- Intercell keyPerson Chief_executive_officer.
- Intercell locationCity Vienna.
- Intercell locationCountry Austria.
- Intercell netIncome "2.552E8".
- Intercell numberOfEmployees "410".
- Intercell operatingIncome "2.512E8".
- Intercell product Vaccine.
- Intercell revenue "3.42E7".
- Intercell successor Valneva_SE.
- Intercell type Aktiengesellschaft.
- Intercell wikiPageExternalLink www.intercell.com.
- Intercell wikiPageID "17861621".
- Intercell wikiPageLength "5620".
- Intercell wikiPageOutDegree "33".
- Intercell wikiPageRevisionID "659664380".
- Intercell wikiPageWikiLink Adjuvant.
- Intercell wikiPageWikiLink Aktiengesellschaft.
- Intercell wikiPageWikiLink Antigen.
- Intercell wikiPageWikiLink Austria.
- Intercell wikiPageWikiLink Biotechnology.
- Intercell wikiPageWikiLink Category:Biotechnology_companies.
- Intercell wikiPageWikiLink Category:Companies_based_in_Vienna.
- Intercell wikiPageWikiLink Category:Companies_established_in_1998.
- Intercell wikiPageWikiLink Chairman.
- Intercell wikiPageWikiLink Chief_executive_officer.
- Intercell wikiPageWikiLink Clinical_trial.
- Intercell wikiPageWikiLink File:Intercell.svg.
- Intercell wikiPageWikiLink Hepatitis_C.
- Intercell wikiPageWikiLink Influenza.
- Intercell wikiPageWikiLink Iomai.
- Intercell wikiPageWikiLink Japanese_encephalitis.
- Intercell wikiPageWikiLink Maryland.
- Intercell wikiPageWikiLink Merck_&_Co..
- Intercell wikiPageWikiLink Novartis.
- Intercell wikiPageWikiLink OTCQX.
- Intercell wikiPageWikiLink OTC_Markets_Group.
- Intercell wikiPageWikiLink Pharmaceutical_company.
- Intercell wikiPageWikiLink Pharmaceutical_industry.
- Intercell wikiPageWikiLink Research_Institute_of_Molecular_Pathology.
- Intercell wikiPageWikiLink Research_spin-off.
- Intercell wikiPageWikiLink Sanofi.
- Intercell wikiPageWikiLink Sanofi-Aventis.
- Intercell wikiPageWikiLink Supervisory_board.
- Intercell wikiPageWikiLink United_States_Department_of_Health_and_Human_Services.
- Intercell wikiPageWikiLink Vaccine.
- Intercell wikiPageWikiLink Valneva_SE.
- Intercell wikiPageWikiLink Vienna.
- Intercell wikiPageWikiLink Vienna_Stock_Exchange.
- Intercell wikiPageWikiLink Wiener_Börse.
- Intercell wikiPageWikiLinkText "Intercell".
- Intercell assets "2.252E8".
- Intercell equity "1.211E8".
- Intercell fate "Merged with Vivalis SA".
- Intercell foundation "1998".
- Intercell hasPhotoCollection Intercell.
- Intercell industry Biotechnology.
- Intercell intl "yes".
- Intercell keyPeople "Thomas Lingelbach , Michel Gréco".
- Intercell locationCity Vienna.
- Intercell locationCountry Austria.
- Intercell logo "120".
- Intercell name "Intercell AG".
- Intercell numEmployees "410".
- Intercell products "Development of vaccines".
- Intercell revenue "3.42E7".
- Intercell successor Valneva_SE.
- Intercell tradedAs "OTCQX: INRLY".
- Intercell tradedAs "WBAG: ICLL".
- Intercell type Aktiengesellschaft.
- Intercell wikiPageUsesTemplate Template:Austria-company-stub.
- Intercell wikiPageUsesTemplate Template:Infobox_company.
- Intercell wikiPageUsesTemplate Template:Official_website.
- Intercell wikiPageUsesTemplate Template:Portal.
- Intercell wikiPageUsesTemplate Template:Reflist.
- Intercell subject Category:Biotechnology_companies.
- Intercell subject Category:Companies_based_in_Vienna.
- Intercell subject Category:Companies_established_in_1998.
- Intercell hypernym Company.
- Intercell type Agent.
- Intercell type Article.
- Intercell type Company.
- Intercell type Organisation.
- Intercell type Article.
- Intercell type Company.
- Intercell type Establishment.
- Intercell type Organization.
- Intercell type Agent.
- Intercell type SocialPerson.
- Intercell type Thing.
- Intercell type Q43229.
- Intercell comment "Intercell AG was a biotechnology company based in Vienna which focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases. Intercell was formed in 1998 as a spin-off of the Research Institute of Molecular Pathology (IMP) in Vienna.It employs 400 people in Austria, Scotland and the United States.It has been listed on the Vienna Stock Exchange since February 28, 2005.".